<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36155748</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-8391</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>12</Day></PubDate></JournalIssue><Title>British medical bulletin</Title><ISOAbbreviation>Br Med Bull</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and the heart.</ArticleTitle><Pagination><StartPage>4</StartPage><EndPage>11</EndPage><MedlinePgn>4-11</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ldac022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/bmb/ldac022</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is evidence for a bi-directional relationship between COVID-19 and the cardiovascular (CV) system.</AbstractText><AbstractText Label="SOURCE OF DATA">Published literature.</AbstractText><AbstractText Label="AREAS OF AGREEMENT">Pre-existing heart failure (HF) increases the risk of mortality with COVID-19. CV complications are recognized, including increased rates of acute coronary syndromes, HF, arrhythmia and myocarditis. Drugs targeting the angiotensin system are safe and may provide prognostic benefit.</AbstractText><AbstractText Label="AREAS OF CONTROVERSY">Vaccination as a cause of myocarditis remains a key area of contention.</AbstractText><AbstractText Label="GROWING POINTS">As the pandemic progresses, we are gaining more data about the long-term effects of COVID-19 on the CV system: long COVID, and medium-to-long-term increases in CV risk.</AbstractText><AbstractText Label="AREAS TIMELY FOR DEVELOPING RESEARCH">Large-scale longitudinal studies will shed light on long-term CV outcomes with COVID-19. Furthermore, the differential effects of COVID-19 variants on the CV system must be investigated.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonaugh</LastName><ForeName>Benedict</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>East Sussex Healthcare NHS Trust, Hastings TN37 7PT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Gallagher</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Medicine &amp; Sciences, Faculty of Life Sciences &amp; Medicine, King's College London, London SE5 9NU, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br Med Bull</MedlineTA><NlmUniqueID>0376542</NlmUniqueID><ISSNLinking>0007-1420</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">heart</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>15</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36155748</ArticleId><ArticleId IdType="pmc">PMC9619476</ArticleId><ArticleId IdType="doi">10.1093/bmb/ldac022</ArticleId><ArticleId IdType="pii">6713905</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li Xet al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds HR, Adhikari S, Pulgarin Cet al. . Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med 2020;382:2441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Offringa-Hup AK, Logtenberg SJJet al. . Discontinuation of antihypertensive medications on the outcome of hospitalized patients with severe acute respiratory syndrome-coronavirus 2. Hypertension 2021;78:165&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189257</ArticleId><ArticleId IdType="pubmed">34106731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T, Cau A, Cheng MPet al. . Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in COVID-19: meta-analysis/meta-regression adjusted for confounding factors. CJC Open 2021;3:965&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023793</ArticleId><ArticleId IdType="pubmed">33842874</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte M, Pelorosso F, Nicolosi LNet al. . Telmisartan for treatment of Covid-19 patients: an open multicenter randomized clinical trial. EClinicalMedicine 2021;37:100962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8225700</ArticleId><ArticleId IdType="pubmed">34189447</ArticleId></ArticleIdList></Reference><Reference><Citation>South AM, Tomlinson L, Edmonston Det al. . Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol 2020;16:305&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118703</ArticleId><ArticleId IdType="pubmed">32246101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rysz S, Al-Saadi J, Sjostrom Aet al. . COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nat Commun 2021;12:2417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8065208</ArticleId><ArticleId IdType="pubmed">33893295</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, Vikse J, Benoit Set al. . Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta 2020;507:167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195008</ArticleId><ArticleId IdType="pubmed">32348783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Li X, Song Qet al. . Assessment of Hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Netw Open 2020;3:e2011122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290402</ArticleId><ArticleId IdType="pubmed">32525548</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni Let al. . Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021;17:751&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CAet al. . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran Ket al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium C-CC, Group LS . Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J 2022;43:1104&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">34734634</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Gallagher K, Shek A, Bean DMet al. . Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19. BMC Cardiovasc Disord 2021;21:327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254437</ArticleId><ArticleId IdType="pubmed">34217220</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestjens SMT, Spoorenberg SMC, Rijkers GTet al. . High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology 2017;22:1000&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28221010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen Bet al. . Association of Cardiac Injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Yet al. . COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020;17:543&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Tabas I, Fredman Get al. . Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014;114:1867&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078767</ArticleId><ArticleId IdType="pubmed">24902971</ArticleId></ArticleIdList></Reference><Reference><Citation>Timpau AS, Miftode RS, Leca Det al. . A real Pandora's box in pandemic times: a narrative review on the acute cardiac injury due to COVID-19. Life (Basel) 2022;12:1085. 10.3390/life12071085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071085</ArticleId><ArticleId IdType="pmc">PMC9318707</ArticleId><ArticleId IdType="pubmed">35888173</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuchowski MF, Winkler MS, Skirecki Tet al. . The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102044</ArticleId><ArticleId IdType="pubmed">33965003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki E, Anyfanti P, Gavriilaki Met al. . Endothelial dysfunction in COVID-19: lessons learned from coronaviruses. Curr Hypertens Rep 2020;22:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449866</ArticleId><ArticleId IdType="pubmed">32852642</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z, Mamas MA. Cardiovascular health care implications of the COVID-19 pandemic. Cardiol Clin 2022;40:389&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8960181</ArticleId><ArticleId IdType="pubmed">35851462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chieffo A, Stefanini GG, Price Set al. . EAPCI position statement on invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur Heart J 2020;41:1839&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239193</ArticleId><ArticleId IdType="pubmed">32405641</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo O, D'Ascenzo F, Angelini Fet al. . Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med 2020;383:88&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224608</ArticleId><ArticleId IdType="pubmed">32343497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev 2021;26:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383122</ArticleId><ArticleId IdType="pubmed">32720082</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Taieb Pet al. . Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation 2020;142:342&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromage DI, Cannata A, Rind IAet al. . The impact of COVID-19 on heart failure hospitalization and management: report from a heart failure unit in London during the peak of the pandemic. Eur J Heart Fail 2020;22:978&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300902</ArticleId><ArticleId IdType="pubmed">32478951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Anyu A, Badawy L, Cannata Aet al. . Long-term outcomes after heart failure hospitalization during the COVID-19 pandemic: a multisite report from heart failure referral centers in London. ESC Heart Fail 2021;8:4701&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653039</ArticleId><ArticleId IdType="pubmed">34477319</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua A, O'Gallagher K, Sado Det al. . Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J 2020;41:2130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184427</ArticleId><ArticleId IdType="pubmed">32227076</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Kotecha T, Razvi Yet al. . COVID-19: myocardial injury in survivors. Circulation 2020;142:1120&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R, Sakamoto A, Kawai Ket al. . Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol 2021;77:314&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevorach D, Anis E, Cedar Net al. . Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med 2021;385:2140&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531987</ArticleId><ArticleId IdType="pubmed">34614328</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss Set al. . Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med 2021;385:2132&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevorach D, Anis E, Cedar Net al. . Myocarditis after BNT162b2 vaccination in Israeli adolescents. N Engl J Med 2022;386:998&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8823652</ArticleId><ArticleId IdType="pubmed">35081295</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Mei XW, Handunnetthi Let al. . Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med 2022;28:410&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dherange P, Lang J, Qian Pet al. . Arrhythmias and COVID-19: a review. JACC Clin Electrophysiol 2020;6:1193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417167</ArticleId><ArticleId IdType="pubmed">32972561</ArticleId></ArticleIdList></Reference><Reference><Citation>Coromilas EJ, Kochav S, Goldenthal Iet al. . Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol 2021;14:e009458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982128</ArticleId><ArticleId IdType="pubmed">33554620</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood J, Shingleton J, Bennett Eet al. . Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): prospective, national surveillance, United Kingdom and Ireland, 2020. Lancet Reg Health Eur 2021;3:100075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132575</ArticleId><ArticleId IdType="pubmed">34027512</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny Jet al. . Clinical characteristics of 58 children with a Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020;324:259&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J, Abdel-Mannan O, Grant Ket al. . 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health 2021;5:473&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe Bet al. . Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28:583&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell Jet al. . Long covid-mechanisms, risk factors, and management. BMJ 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky Tet al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm 2021;18:508&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EMet al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>UKHSA . The Effectiveness of Vaccination against Long COVID, www.gov.uk, 2022</Citation></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MRet al. . COVID-19 and cardiovascular disease: from bench to bedside. Circ Res 2021;128:1214&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI. Insight 2021;6. 10.1172/jci.insight.148980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148980</ArticleId><ArticleId IdType="pmc">PMC8410051</ArticleId><ArticleId IdType="pubmed">34061779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>